Subscribe to Snippets

Stanford v. Roche: Part II: The Supreme Court Has Spoken

  • Private: Christopher D. Butts Kevin E. Noonan
  • Spring 2011 (snippets)
  • Snippets

Practices & Technologies

Trade Secrets Opinions & Counseling Litigation & Appeals Patent Portfolio Management Patent Prosecution Trademark Biotechnology & Pharmaceuticals Chemical Software & Computing Electrical Mechanical & Materials Medical Device & Diagnostics Networking & Telecommunications

AI News Roundup – Disney and Universal sue Midjourney for copyright infringement, EU considers pause on AI Act regulations, Google partners with U.S. government to track hurricanes using AI, and more

MBHB Partner Kevin Noonan on how the Teva Orange Book Defeat is impacting pharma patent strategy in Bloomberg Law

AI News Roundup – UK government’s AI copyright plan suffers setback, Reddit sues Anthropic over unauthorized data use for AI training, AI helps unlock secrets of Dead Sea Scrolls, and more

About the Authors

Private: Christopher D. Butts

Kevin E. Noonan

Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and pharmaceutical patent law. Over the past 30 years, he has counseled some of the largest biotechnology and pharmaceutical companies in the world on intellectual property issues.
© 2025 McDonnell Boehnen Hulbert & Berghoff LLP snippets is a trademark of McDonnell Boehnen Hulbert & Berghoff LLP. All rights reserved. The information contained in this newsletter reflects the understanding and opinions of the author(s) and is provided to you for informational purposes only. It is not intended to and does not represent legal advice. MBHB LLP does not intend to create an attorney–client relationship by providing this information to you. The information in this publication is not a substitute for obtaining legal advice from an attorney licensed in your particular state. snippets may be considered attorney advertising in some states.
PrevPrevious PostCrafting the Cease and Desist Letter: MedImmune’s Impact on the Patent Owner
Next PostDeciphering the Patent-Eligibility Message in Prometheus, Myriad and ClassenNext
  • contact us
  • client pay
  • privacy policy
  • disclaimer
McDonnell Boehnen Hulbert & Berghoff
Youtube Linkedin-in
  • © 2025 McDonnell Boehnen Hulbert & Berghoff LLP
Search
Menu
People
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Services
Practices Technologies
Intelligence
NewsEventsSnippetsPatently-O BlogPatent Docs
Firm
Diversity & InclusionCommunityAwards & AccoladesOur Clients
Careers
Culture and Development Career Paths Diversity And Inclusion Legal Professionals Business Professionals
LocationContact Us
Client Pay
Menu